118 related articles for article (PubMed ID: 19360305)
1. Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer.
Winder T; Mündlein A; Rhomberg S; Dirschmid K; Hartmann BL; Knauer M; Drexel H; Wenzl E; De Vries A; Lang A
Oncol Rep; 2009 May; 21(5):1283-7. PubMed ID: 19360305
[TBL] [Abstract][Full Text] [Related]
2. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study.
Andreyev HJ; Norman AR; Cunningham D; Oates J; Dix BR; Iacopetta BJ; Young J; Walsh T; Ward R; Hawkins N; Beranek M; Jandik P; Benamouzig R; Jullian E; Laurent-Puig P; Olschwang S; Muller O; Hoffmann I; Rabes HM; Zietz C; Troungos C; Valavanis C; Yuen ST; Ho JW; Croke CT; O'Donoghue DP; Giaretti W; Rapallo A; Russo A; Bazan V; Tanaka M; Omura K; Azuma T; Ohkusa T; Fujimori T; Ono Y; Pauly M; Faber C; Glaesener R; de Goeij AF; Arends JW; Andersen SN; Lövig T; Breivik J; Gaudernack G; Clausen OP; De Angelis PD; Meling GI; Rognum TO; Smith R; Goh HS; Font A; Rosell R; Sun XF; Zhang H; Benhattar J; Losi L; Lee JQ; Wang ST; Clarke PA; Bell S; Quirke P; Bubb VJ; Piris J; Cruickshank NR; Morton D; Fox JC; Al-Mulla F; Lees N; Hall CN; Snary D; Wilkinson K; Dillon D; Costa J; Pricolo VE; Finkelstein SD; Thebo JS; Senagore AJ; Halter SA; Wadler S; Malik S; Krtolica K; Urosevic N
Br J Cancer; 2001 Sep; 85(5):692-6. PubMed ID: 11531254
[TBL] [Abstract][Full Text] [Related]
3. G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.
Fiala O; Buchler T; Mohelnikova-Duchonova B; Melichar B; Matejka VM; Holubec L; Kulhankova J; Bortlicek Z; Bartouskova M; Liska V; Topolcan O; Sedivcova M; Finek J
Tumour Biol; 2016 May; 37(5):6823-30. PubMed ID: 26662311
[TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological study of K-ras mutations in colorectal tumors in Saudi Arabia.
Zahrani A; Kandil M; Badar T; Abdelsalam M; Al-Faiar A; Ismail A
Tumori; 2014; 100(1):75-9. PubMed ID: 24675495
[TBL] [Abstract][Full Text] [Related]
5. Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.
Ren J; Li G; Ge J; Li X; Zhao Y
Dis Colon Rectum; 2012 Aug; 55(8):913-23. PubMed ID: 22810479
[TBL] [Abstract][Full Text] [Related]
6. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
[TBL] [Abstract][Full Text] [Related]
7. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
[TBL] [Abstract][Full Text] [Related]
8. K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Karapetis CS; Khambata-Ford S; Jonker DJ; O'Callaghan CJ; Tu D; Tebbutt NC; Simes RJ; Chalchal H; Shapiro JD; Robitaille S; Price TJ; Shepherd L; Au HJ; Langer C; Moore MJ; Zalcberg JR
N Engl J Med; 2008 Oct; 359(17):1757-65. PubMed ID: 18946061
[TBL] [Abstract][Full Text] [Related]
9. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
10. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.
Andreyev HJ; Norman AR; Cunningham D; Oates JR; Clarke PA
J Natl Cancer Inst; 1998 May; 90(9):675-84. PubMed ID: 9586664
[TBL] [Abstract][Full Text] [Related]
11. Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.
Zhang H; Zheng X; Ji T; Fu L; Bai D; Liao Y; Zhang H; Ding Y; Zheng L
Cell Biochem Biophys; 2012 Apr; 62(3):415-20. PubMed ID: 22048888
[TBL] [Abstract][Full Text] [Related]
12. The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.
Hurwitz HI; Yi J; Ince W; Novotny WF; Rosen O
Oncologist; 2009 Jan; 14(1):22-8. PubMed ID: 19144677
[TBL] [Abstract][Full Text] [Related]
13. A relationship between K-ras gene mutations and some clinical and histologic variables in patients with primary colorectal carcinoma.
Beránek M; Bures J; Palicka V; Jandík P; Langr F; Nejedlá E
Clin Chem Lab Med; 1999 Jul; 37(7):723-7. PubMed ID: 10510729
[TBL] [Abstract][Full Text] [Related]
14. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.
Poehlmann A; Kuester D; Meyer F; Lippert H; Roessner A; Schneider-Stock R
Pathol Res Pract; 2007; 203(7):489-97. PubMed ID: 17629419
[TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
17. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study.
Brink M; de Goeij AF; Weijenberg MP; Roemen GM; Lentjes MH; Pachen MM; Smits KM; de Bruïne AP; Goldbohm RA; van den Brandt PA
Carcinogenesis; 2003 Apr; 24(4):703-10. PubMed ID: 12727799
[TBL] [Abstract][Full Text] [Related]
18. [Clinical relevance of the K-ras oncogene in colorectal cancer: experience in a Mexican population].
Cabrera-Mendoza F; Gainza-Lagunes S; Castañeda-Andrade I; Castro-Zárate A
Rev Gastroenterol Mex; 2014; 79(3):166-70. PubMed ID: 25216999
[TBL] [Abstract][Full Text] [Related]
19. The type of K-ras mutation determines prognosis in colorectal cancer.
Cerottini JP; Caplin S; Saraga E; Givel JC; Benhattar J
Am J Surg; 1998 Mar; 175(3):198-202. PubMed ID: 9560119
[TBL] [Abstract][Full Text] [Related]
20. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
